Market Closed -
Other stock markets
|
|
5-day change | 1st Jan Change | |
2,155.5 JPY | +3.36% | -3.08% | -8.35% |
Dec. 05 | Olympus Buys Back 8.77 Million Shares | MT |
Nov. 20 | Olympus Corporation Announces Study Results Show the S Sustained Clinical Benefits of Spiration Valve System At 24 Months | CI |
Business Summary
- medical equipments (53.1%): surgical endoscopes, ultrasound endoscopes, etc.;
- medical devices (31.7%): medical devices for gastroenterology, urology, respiratory management, ENT and gynecology;
- scientific analysis instruments and microscopes (13.7%);
- other (1.5%): biomedical materials, orthopedic equipment, etc.
Net sales break down geographically as follows: Japan (15.6%), China (14.4%), Asia and Oceania (8.9%), North America (33.8%), Europe (25.1%) and other (2.2%).
Number of employees : 32,844
Sales per Business
JPY in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Endoscope
62.6
%
| 461,547 | 53.1 % | 551,823 | 62.6 % | +19.56% |
Therapy Instrument
36.1
%
| 275,586 | 31.7 % | 318,207 | 36.1 % | +15.47% |
Other
1.3
%
| 12,629 | 1.5 % | 11,893 | 1.3 % | -5.83% |
Sales per region
JPY in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
North America
36.5
%
| 293,441 | 33.8 % | 322,167 | 36.5 % | +9.79% |
Europe
25.2
%
| 217,858 | 25.1 % | 222,164 | 25.2 % | +1.98% |
Japan
13.9
%
| 135,197 | 15.6 % | 122,516 | 13.9 % | -9.38% |
China
13.3
%
| 125,406 | 14.4 % | 117,094 | 13.3 % | -6.63% |
Asia and Oceania
8.8
%
| 77,484 | 8.9 % | 77,807 | 8.8 % | +0.42% |
Other
2.3
%
| 19,481 | 2.2 % | 20,175 | 2.3 % | +3.56% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Stefan Kaufmann
CEO | Chief Executive Officer | 55 | 2017 |
Chikashi Takeda
DFI | Director of Finance/CFO | 61 | 2020 |
Yasuo Takeuchi
CHM | Chairman | 66 | 1980 |
Akira Hasegawa
CTO | Chief Tech/Sci/R&D Officer | - | - |
Yoshio Tashiro
CTO | Chief Tech/Sci/R&D Officer | - | - |
André Roggan
CTO | Chief Tech/Sci/R&D Officer | 61 | 2021 |
Stephen Kneebone
CTO | Chief Tech/Sci/R&D Officer | 63 | - |
Katsuyuki Saito
CTO | Chief Tech/Sci/R&D Officer | - | - |
Nacho Abia
COO | Chief Operating Officer | 55 | 2017 |
Compliance Officer | - | 2020 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Jimmy C. Beasley
BRD | Director/Board Member | 60 | 2019 |
Sumitaka Fujita
BRD | Director/Board Member | 81 | 2012 |
Gary Pruden
BRD | Director/Board Member | 61 | 2022 |
Yasushi Shingai
BRD | Director/Board Member | 67 | - |
Yasumasa Masuda
BRD | Director/Board Member | 66 | 2018 |
Yasuo Takeuchi
CHM | Chairman | 66 | 1980 |
Robert Hale
BRD | Director/Board Member | 39 | 2019 |
Sachiko Ichikawa
BRD | Director/Board Member | 56 | - |
Stefan Kaufmann
CEO | Chief Executive Officer | 55 | 2017 |
Kohei Kan
BRD | Director/Board Member | 63 | 2022 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 0 | 1,266,178,700 | 1,201,905,891 ( 94.92 %) | 44,638,731 ( 3.525 %) | 94.92 % |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
OLYMPUS CORPORATION 4.87% | 61,715,407 | 4.87% | 814,613,132 $ |
OHARA INC. 1.57% | 400,000 | 1.57% | 3,312,092 $ |
USHIO INC. 0.45% | 560,575 | 0.45% | 6,773,758 $ |
Company contact information
Olympus Corp.
3-1 Nishi-Shinjuku 2-chome Shinjuku-ku
163-0914, Tokyo
+81 3 3340 2111
http://www.olympus.co.jp
Group companies
Name | Category and Sector |
---|---|
Olympus Global Treasury Services Ltd.
|
Commercial Services - Miscellaneous Commercial Services
|
Olympus Medical Systems India Pvt Ltd.
|
Distribution Services - Medical Distributors
|
Sector
Sales per Business
Sales per region
Trading Rating :
Investor Rating :
ESG Refinitiv :
A-
Sell
Buy

Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
2,085.5JPY
Average target price
2,324.62JPY
Spread / Average Target
+11.47%
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-8.35% | 16 926 M $ | |
-10.73% | 190 B $ | |
-17.32% | 162 B $ | |
+16.65% | 109 B $ | |
+12.13% | 63 226 M $ | |
-8.59% | 48 897 M $ | |
-7.72% | 41 758 M $ | |
-14.55% | 37 357 M $ | |
+16.39% | 30 925 M $ | |
-22.67% | 23 673 M $ |
- Stock
- Equities
- Stock Olympus Corporation - Japan Exchange
- Company Olympus Corporation